SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+34.67%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$555M
AUM Growth
+$555M
(+54%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
19.36%
Top 10 Holdings %
Top 10 Hldgs %
64.54%
Holding
91
New
25
Increased
22
Reduced
13
Closed
17
Top Buys
| 1 |
THER
THERATECHNOLOGIES INC COM
THER
|
$26.9M |
| 2 |
Krystal Biotech
KRYS
|
$12.1M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$11M |
| 4 |
AstraZeneca
AZN
|
$9.65M |
| 5 |
C4 Therapeutics
CCCC
|
$7.23M |
Top Sells
| 1 |
NVTA
Invitae Corporation
NVTA
|
$10.2M |
| 2 |
ESSA Pharma
EPIX
|
$8.88M |
| 3 |
Vericel Corp
VCEL
|
$7.31M |
| 4 |
Mersana Therapeutics
MRSN
|
$5.5M |
| 5 |
Exelixis
EXEL
|
$4.71M |
Sector Composition
| 1 | Healthcare | 90.73% |
| 2 | Consumer Staples | 1.79% |
| 3 | Real Estate | 0.62% |
| 4 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioAtla
BCAB
$26.7M
| $162M | 29.12% | 3,179,362 | – | – |
|
|
2
ESSA Pharma
EPIX
$11.4M
| $60.1M | 10.84% | 2,070,052 -305,629 | -13% | -$8.88M |
|
|
THER
3
DELISTED
THERATECHNOLOGIES INC COM
THER
| $26.9M | 4.84% | +6,951,347 | New | +$26.9M |
|
|
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $20.9M | 3.76% | 3,380,979 +1,783,700 | +112% | +$11M |
|
5
Lantheus
LNTH
$3.73B
| $20.7M | 3.72% | 967,372 +225,287 | +30% | +$4.81M |
|
|
6
C4 Therapeutics
CCCC
$185M
| $17.2M | 3.09% | 464,068 +195,520 | +73% | +$7.23M |
|
|
7
Krystal Biotech
KRYS
$4.27B
| $12.9M | 2.32% | 166,844 +156,421 | +1,501% | +$12.1M |
|
|
8
AstraZeneca
AZN
$248B
| $12.9M | 2.32% | 258,446 +194,162 | +302% | +$9.65M |
|
9
Xenon Pharmaceuticals
XENE
$2.98B
| $12.7M | 2.28% | 708,117 +150,000 | +27% | +$2.68M |
|
10
iRadimed
IRMD
$921M
| $12.4M | 2.24% | 482,070 +178,072 | +59% | +$4.59M |
|
11
The Beauty Health Co
SKIN
$264M
| $9.94M | 1.79% | 920,716 +504,165 | +121% | +$5.45M |
|
12
Galecto
GLTO
$4.21M
| $9.19M | 1.66% | 1,512,648 | – | – |
|
13
Surmodics
SRDX
$487M
| $8.65M | 1.56% | 154,275 +61,300 | +66% | +$3.44M |
|
|
INBX
14
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $8.06M | 1.45% | 401,493 +187,686 | +88% | +$3.77M |
|
15
Natera
NTRA
$23.1B
| $7.94M | 1.43% | 78,239 +4,050 | +5% | +$411K |
|
|
ITMR
16
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $6.47M | 1.17% | 270,080 +129,556 | +92% | +$3.1M |
|
|
MSON
17
DELISTED
Misonix Inc
MSON
| $5.9M | 1.06% | 301,333 | – | – |
|
18
Vaxcyte
PCVX
$4B
| $5.8M | 1.05% | +293,650 | New | +$5.8M |
|
19
Lyra Therapeutics
LYRA
$11.5M
| $5.52M | 0.99% | 475,814 +19,676 | +4% | +$228K |
|
20
Assembly Biosciences
ASMB
$190M
| $5.16M | 0.93% | +1,122,000 | New | +$5.16M |
|
21
MiMedx Group
MDXG
$1.05B
| $5.15M | 0.93% | +500,000 | New | +$5.15M |
|
|
FLXN
22
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $4.68M | 0.84% | +522,500 | New | +$4.68M |
|
23
ARS Pharmaceuticals
SPRY
$1.15B
| $4.24M | 0.76% | 97,256 -10,570 | -10% | -$461K |
|
|
24
Exelixis
EXEL
$10.1B
| $4.12M | 0.74% | 182,347 -208,500 | -53% | -$4.71M |
|
25
Repare Therapeutics
RPTX
$71.7M
| $4.09M | 0.74% | +133,324 | New | +$4.09M |
|